Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lester

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Blood|June 1, 1977
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerationsR K Desser, H M Golomb, J E Ultmann, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2006
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M Lichtman, Donna Hollis, Antonius A Miller, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution and Prevents Vein Wall Fibrosis Better than Enoxaparin and an Inhibitor to von Willebrand FactorJ A Diaz, S K Wrobleski, A R Pechota, et al.
Pediatric Blood & Cancer|April 2, 2014
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistanceDavid J Monsma, David M Cherba, Patrick J Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancerEzra E W Cohen, Daniel J Haraf, Rangesh Kunnavakkam, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Annals of Internal Medicine|June 1, 1980
Cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (COMLA) combination sequential chemotherapy for advanced diffuse histiocytic lymphomaD L Sweet, H M Golomb, J E Ultmann, et al.
Blood|June 1, 1977
Prognostic classification of Hodgkin disease in pathologic stage III, based on anatomic considerationsR K Desser, H M Golomb, J E Ultmann, et al.
Cancer|July 1, 1978
Non-Hodgkin's lymphoma, poorly differentiated lymphocytic and mixed cell types: results of sequential staging procedures, response to therapy, and survival of 100 patientsJ D Bitran, H M Golomb, J E Ultmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2006
Prospective evaluation of the relationship of patient age and paclitaxel clinical pharmacology: Cancer and Leukemia Group B (CALGB 9762)Stuart M Lichtman, Donna Hollis, Antonius A Miller, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|March 20, 2016
P-Selectin Inhibition Therapeutically Promotes Thrombus Resolution and Prevents Vein Wall Fibrosis Better than Enoxaparin and an Inhibitor to von Willebrand FactorJ A Diaz, S K Wrobleski, A R Pechota, et al.
Pediatric Blood & Cancer|April 2, 2014
Using a rhabdomyosarcoma patient-derived xenograft to examine precision medicine approaches and model acquired resistanceDavid J Monsma, David M Cherba, Patrick J Richardson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancerEzra E W Cohen, Daniel J Haraf, Rangesh Kunnavakkam, et al.
Cancer|February 11, 2004
A randomized controlled trial of darbepoetin alfa administered as a fixed or weight-based dose using a front-loading schedule in patients with anemia who have nonmyeloid malignanciesPaul J Hesketh, Francis Arena, Dhimant Patel, et al.
Pageof 11